FIELD: health care.
SUBSTANCE: invention relates to medicine, namely to cardiology and radiation diagnostics, and can be used to diagnose heart failure with a preserved left ventricular ejection fraction in patients with coronary heart disease against the background of non-occlusive atherosclerosis of the coronary arteries. The global reserve of coronary blood flow is determined using dynamic single-photon emission computed tomography of the myocardium. At a value of 2.27 or less, chronic heart failure with a preserved left ventricular ejection fraction is diagnosed.
EFFECT: method enables to predict a chronic heart failure in patients with coronary artery disease against the background of non-occlusive atherosclerosis of the coronary arteries at the preclinical stage of development, which makes it possible to identify a priority group of patients with an increased risk of cardiovascular complications for dispensary observation and the appointment of personalized treatment, by determining the global reserve of coronary blood flow.
1 cl, 3 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EARLY DIAGNOSIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH NON-OBSTRUCTIVE ATHEROSCLEROSIS OF CORONARY ARTERIES BY ANALYSIS OF HEART RATE VARIABILITY | 2023 |
|
RU2800862C1 |
| METHOD FOR PREDICTING RISKS OF PROGRESSION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH NON-OBSTRUCTIVE ATHEROSCLEROSIS OF CORONARY ARTERIES DURING 12 MONTHS OF OBSERVATION | 2023 |
|
RU2804705C1 |
| METHOD FOR NON-INVASIVE EARLY DIAGNOSIS OF CORONARY MICROVASCULAR LESIONS IN PATIENTS WITH NON-OBSTRUCTIVE ATHEROSCLEROSIS OF THE CORONARY ARTERIES | 2022 |
|
RU2781411C1 |
| METHOD FOR PREDICTING ADVERSE CARDIOVASCULAR EVENTS FOR A PERIOD OF 12 MONTHS IN PATIENTS WITH CHRONIC HEART FAILURE WITH RECURRENCE OF ANGINA AFTER MYOCARDIAL REVASCULARIZATION | 2018 |
|
RU2677611C1 |
| METHOD FOR PHENOTYPING CHRONIC HEART FAILURE BASED ON METABOLOMIC PROFILING | 2024 |
|
RU2841230C1 |
| METHOD FOR DIAGNOSING MYOCARDIAL DYSFUNCTION WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION DEPENDING ON STATE OF MEMBRANE POTENTIAL OF BLOOD LEUKOCYTES IN PATIENTS WITH MYOCARDIAL INFARCTION | 2023 |
|
RU2832976C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE DECOMPENSATION OF ISCHEMIC CHRONIC HEART FAILURE WITH SYSTOLIC DYSFUNCTION OF THE LEFT VENTRICLE OF THE HEART AFTER COMPLETE MYOCARDIAL REVASCULARIZATION | 2021 |
|
RU2770271C1 |
| METHOD FOR PREDICTING THE ONE-YEAR RISK OF ADVERSE CARDIOVASCULAR EVENTS IN MEN AFTER DECOMPENSATION OF CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION AND OBSTRUCTIVE SLEEP APNEA SYNDROME | 2021 |
|
RU2767266C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING UNFAVOURABLE CLINICAL COURSE OF HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION FOR 12 MONTHS | 2024 |
|
RU2826921C1 |
| METHOD OF DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION | 2023 |
|
RU2814392C1 |
